Pharmacokinetics of chloroquine and monodesethylchloroquine in pregnancy

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 3, 2010, Pages 1186-1192

  Karunajeewa, Harin A ^a,b   Salman, Sam ^a   Mueller, Ivo ^c   Baiwog, Francisca ^c   Gomorrai, Servina ^c   Law, Irwin ^a   Page Sharp, Madhu ^a,d   Rogerson, Stephen ^e   Siba, Peter ^c   Ilett, Kenneth F ^a,f   Davis, Timothy M E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b WESTERN HEALTH   (Australia)

^c PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^d CURTIN UNIVERSITY   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; DEETHYLCHLOROQUINE; FANSIDAR; MONODESETHYLCHLOROQUINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HEMODYNAMICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALARIA; PAPUA NEW GUINEA; PREGNANCY; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SINGLE DRUG DOSE; THIRD TRIMESTER PREGNANCY;

ADOLESCENT; ADULT; ANTIMALARIALS; AREA UNDER CURVE; BAYES THEOREM; CHLOROQUINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALARIA, FALCIPARUM; MODELS, BIOLOGICAL; PAPUA NEW GUINEA; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77149154948     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01269-09     Document Type: Article

References (35)

1. Aderounmu, A. F., L. A. Salako, B. Lindstrom, O. Walker, and L. Ekman. 1986. Comparison of the pharmacokinetics of chloroquine after single intravenous and intramuscular administration in healthy Africans. Br. J. Clin. Pharmacol. 22:559-564.
2. Adjepon-Yamoah, K. K., D. Ofori-Adjei, N. M. Woolhouse, and B. Lindstrom. 1986. Whole-blood single-dose kinetics of chloroquine and desethylchloroquine in Africans. Ther. Drug Monit. 8:195-199.
3. Ajayi, F. O., L. A. Salako, and J. O. Kuye. 1989. Comparison of the partitioning in vitro of chloroquine and its desethyl metabolites between the erythrocytes and plasma of healthy subjects and those with falciparum malaria. Afr. J. Med. Med. Sci. 18:95-100.
4. Anderson, B. J., and N. H. Holford. 2008. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu. Rev. Pharmacol. Toxicol. 48:303-332.
5. Anderson, G. D. 2006. Using pharmacokinetics to predict the effects of pregnancy and maternal-infant transfer of drugs during lactation. Expert Opin. Drug Metab. Toxicol. 2:947-960.
6. Basco, L. K., and P. Ringwald. 2003. In vitro activities of piperaquine and other 4-aminoquinolines against clinical isolates of Plasmodium falciparum in Cameroon. Antimicrob. Agents Chemother. 47:1391-1394.
7. Bergqvist, Y., and B. Domeij-Nyberg. 1983. Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma. J. Chromatogr. 272:137-148.
8. Bustos, D. G., J. E. Lazaro, F. Gay, A. Pottier, C. J. Laracas, B. Traore, and B. Diquet. 2002. Pharmacokinetics of sequential and simultaneous treatment with the combination chloroquine and sulfadoxine-pyrimethamine in acute uncomplicated Plasmodium falciparum malaria in the Philippines. Trop. Med. Int. Health 7:584-591.
9. Chukwuani, M. C., O. O. Bolaji, C. O. Onyeji, O. N. Makinde, and F. A. Ogunbona. 2004. Evidence for increased metabolism of chloroquine during the early third trimester of human pregnancy. Trop. Med. Int. Health 9:601-605.
10. Edwards, G., S. Looareesuwan, A. J. Davies, Y. Wattanagoon, R. E. Phillips, and D. A. Warrell. 1988. Pharmacokinetics of chloroquine in Thais: plasma and red-cell concentrations following an intravenous infusion to healthy subjects and patients with Plasmodium vivax malaria. Br. J. Clin. Pharmacol. 25:477-485.
11. Ette, E. I., E. E. Essien, W. O. Thomas, and E. A. Brown-Awala. 1989. Pharmacokinetics of chloroquine and some of its metabolites in healthy volunteers: a single dose study. J. Clin. Pharmacol. 29:457-462.
12. Frisk-Holmberg, M., Y. Bergqvist, E. Termond, and B. Domeij-Nyberg. 1984. The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects. Eur. J. Clin. Pharmacol. 26:521-530.
13. Gerhardy, C. L., and M. Garrett. 2002. Obstetrics and gynaecology for nurses and midwives, 5th ed. Lutheran School of Nursing, Madang, Papua New Guinea.
14. Gustafsson, L. L., O. Walker, G. Alvan, B. Beermann, F. Estevez, L. Gleisner, B. Lindstrom, and F. Sjoqvist. 1983. Disposition of chloroquine in man after single intravenous and oral doses. Br. J. Clin. Pharmacol. 15:471-479.
15. Hodge, L. S., and T. S. Tracy. 2007. Alterations in drug disposition during pregnancy: implications for drug therapy. Expert Opin. Drug Metab. Toxicol. 3:557-571.
16. Karlsson, M. O., and L. B. Sheiner. 1993. The importance of modeling interoccasion variability in population pharmacokinetic analyses. J. Pharmacokinet. Biopharm. 21:735-750.
17. Karunajeewa, H. A., K. F. Ilett, I. Mueller, P. Siba, I. Law, M. Page-Sharp, E. Lin, J. Lammey, K. T. Batty, and T. M. Davis. 2008. Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria. Antimicrob. Agents Chemother. 52:237-243.
18. Karunajeewa, H. A., S. Salman, I. Mueller, F. Baiwog, S. Gomorrai, I. Law, M. Page-Sharp, S. Rogerson, P. Siba, K. F. Ilett, and T. M. Davis. 2009. The pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnancy. Antimicrob. Agents Chemother. 53:4368-4376.
19. Kim, K. A., J. Y. Park, J. S. Lee, and S. Lim. 2003. Cytochrome P450 2C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes. Arch. Pharm. Res. 26:631-637.
20. Krishna, S., and N. J. White. 1996. Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Clin. Pharmacokinet. 30:263-299.
21. Lee, S. J., R. McGready, C. Fernandez, K. Stepniewska, M. K. Paw, S. J. Viladpai-Nguen, K. L. Thwai, L. Villegas, P. Singhasivanon, B. M. Greenwood, N. J. White, and F. Nosten. 2008. Chloroquine pharmacokinetics in pregnant and nonpregnant women with vivax malaria. Eur. J. Clin. Pharmacol. 74:987-992.
22. Looareesuwan, S., N. J. White, P. Chanthavanich, G. Edwards, D. D. Nicholl, C. Bunch, and D. A. Warrell. 1986. Cardiovascular toxicity and distribution kinetics of intravenous chloroquine. Br. J. Clin. Pharmacol. 22:31-36.
23. Massele, A. Y., C. Kilewo, Y. Aden Abdi, G. Tomson, V. K. Diwan, O. Ericsson, G. Rimoy, and L. L. Gustafsson. 1997. Chloroquine blood concentrations and malaria prophylaxis in Tanzanian women during the second and third trimesters of pregnancy. Eur. J. Clin. Pharmacol. 52:299-305.
24. Na-Bangchang, K., L. Limpaibul, A. Thanavibul, P. Tan-Ariya, and J. Karbwang. 1994. The pharmacokinetics of chloroquine in healthy Thai subjects and patients with Plasmodium vivax malaria. Br. J. Clin. Pharmacol. 38:278-281.
25. Papua New Guinea Department of Health. 2000. Standard treatment of common illnesses of children in Papua New Guinea, 7th ed. Government of Papua New Guinea, Port Moresby, Papua New Guinea.
26. Projean, D., B. Baune, R. Farinotti, J. P. Flinois, P. Beaune, A. M. Taburet, and J. Ducharme. 2003. In vitro metabolism of chloroquine: identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation. Drug Metab. Dispos. 31:748-754.
27. Tett, S. E., and D. J. Cutler. 1987. Apparent dose-dependence of chloroquine pharmacokinetics due to limited assay sensitivity and short sampling times. Eur. J. Clin. Pharmacol. 31:729-731.
28. Walker, O., L. A. Salako, G. Alvan, O. Ericsson, and F. Sjoqvist. 1987. The disposition of chloroquine in healthy Nigerians after single intravenous and oral doses. Br. J. Clin. Pharmacol. 23:295-301.
29. Ward, S. A., E. J. Sevene, I. M. Hastings, F. Nosten, and R. McGready. 2007. Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. Lancet Infect. Dis. 7:136-144.
30. Wetsteyn, J. C., P. J. De Vries, B. Oosterhuis, and C. J. Van Boxtel. 1995. The pharmacokinetics of three multiple dose regimens of chloroquine: implications for malaria chemoprophylaxis. Br. J. Clin. Pharmacol. 39:696-699.
31. White, N. J. 1985. Clinical pharmacokinetics of antimalarial drugs. Clin. Pharmacokinet. 10:187-215.
32. White, N. J. 2005. Intermittent presumptive treatment for malaria. PLoS Med. 2:e3.
33. World Health Organization. 2003. Assessment and monitoring of antimalarial drugs for the treatment of acute uncomplicated falciparum malaria. WHO/HTM/RBM/2003.50. World Health Organization, Geneva, Switzerland.
34. World Health Organization. 2006. Guidelines for the treatment of malaria. WHO/HTM/MAL/2006.1108. World Health Organization, Geneva, Switzerland.
35. World Health Organization. 2000. Severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 94(Suppl. 1):S1-S90.